— Know what they know.
Not Investment Advice

CATX Short Interest

Perspective Therapeutics, Inc.
1W: -48.3% 1M: -52.4% 3M: -58.5% YTD: -57.4% 1Y: -60.2% 3Y: -59.9% 5Y: -80.9%
$1.19
-0.02 (-1.65%)
 
Weekly Expected Move ±18.3%
$1 $1 $2 $2 $2
AMEX · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 30 · $135.8M mcap · 71M float · 2.74% daily turnover · Short 59% of daily vol
Credit Risk of going bust: higher than 66% of companies Debt: 2.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.4%), Perspective Therapeutics, Inc. would be worth roughly what it owes.
Total debt $4.0M against a stock market value of $135.8M.
Distance to default 3.76 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.9M (short-term plus half of long-term), stock volatility 102.4%; Altman Z -0.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
51.1%
Short Ratio
of total volume
62.0%
20-Day Avg
59.5%
50-Day Avg
▼ Falling
5-Day Trend
3.2M
Short Volume
6.3M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 3,016,616 5,235,723 57.6%
NYSE 178,182 1,014,387 17.6%
BATS 15,533 31,202 49.8%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms